KR100403950B1 - Process for preparing 5-aminomethyl-2-thiophenecarbonitrile·HCl - Google Patents

Process for preparing 5-aminomethyl-2-thiophenecarbonitrile·HCl Download PDF

Info

Publication number
KR100403950B1
KR100403950B1 KR10-2001-0017841A KR20010017841A KR100403950B1 KR 100403950 B1 KR100403950 B1 KR 100403950B1 KR 20010017841 A KR20010017841 A KR 20010017841A KR 100403950 B1 KR100403950 B1 KR 100403950B1
Authority
KR
South Korea
Prior art keywords
formula
compound
reaction
azide
added
Prior art date
Application number
KR10-2001-0017841A
Other languages
Korean (ko)
Other versions
KR20020078025A (en
Inventor
이구
정원혁
박철원
윤석균
김봉찬
이재철
Original Assignee
주식회사 엘지생명과학
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 엘지생명과학 filed Critical 주식회사 엘지생명과학
Priority to KR10-2001-0017841A priority Critical patent/KR100403950B1/en
Publication of KR20020078025A publication Critical patent/KR20020078025A/en
Application granted granted Critical
Publication of KR100403950B1 publication Critical patent/KR100403950B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms

Abstract

본 발명은 경구용 항응혈제(Thrombin Inhibitor)의 중요한 중간체인 하기 화학식 6의 화합물을 효과적으로 합성하는 새로운 방법을 제공한다:The present invention provides a novel method for effectively synthesizing a compound of formula 6, which is an important intermediate of oral anticoagulants (Thrombin Inhibitor):

[화학식 6][Formula 6]

본 발명의 방법에 따라 상기 항응혈제의 중간체를 고수율로 얻을 수 있다.According to the method of the present invention, the intermediate of the anticoagulant can be obtained in high yield.

Description

5-아미노메틸-2-티오펜카보니트릴 염산염의 제조방법{Process for preparing 5-aminomethyl-2-thiophenecarbonitrile·HCl}Process for preparing 5-aminomethyl-2-thiophenecarbonitrile hydrochloride {Process for preparing 5-aminomethyl-2-thiophenecarbonitrileHCl}

본 발명은 하기 화학식 6의 5-(아미노메틸)-2-티오펜카보니트릴 염산염의 새로운 제조방법에 관한 것이다.The present invention relates to a novel process for preparing 5- (aminomethyl) -2-thiophencarbonitrile hydrochloride of formula (6).

[화학식 6][Formula 6]

상기 화학식 6의 화합물은 새로운 경구용 항응혈제(thrombin inhibitor)로 개발되고 있는 원료 의약 물질(국내출원번호: KR1998-0060266, KR1999-0033490, WO 00/39124)의 N-말단 그룹을 구성하는 중요한 부분일 뿐만 아니라 그외의 포유동물의 혈액 응고 예방 및 혈전증 치료 개발에 유용하게 사용되고 있는 화합물( PCT/US95/02558, WO 95/23609)의 한 부분을 이루고 있다. 따라서 상기 화학식 6 화합물을 제조하는데에 관심이 고조되고 있다.The compound of formula 6 is an important oral constituting the N-terminal group of the raw pharmaceutical material (domestic application number: KR1998-0060266, KR1999-0033490, WO 00/39124) that is being developed as a new oral anticoagulant (thrombin inhibitor) It is part of the compound (PCT / US95 / 02558, WO 95/23609), which is not only part but also usefully used for the development of blood clotting prevention and thrombosis treatment in other mammals. Accordingly, there is a growing interest in preparing the above formula (6).

국내 특허출원번호 제 1998-0060266호 및 제 1999-0033490호에서는 다음 반응식 1과 같이 화합물(6)을 제조하는 방법이 제시되어 있다:In Korean Patent Application Nos. 1998-0060266 and 1999-0033490, a method for preparing compound (6) is shown as in Scheme 1.

[반응식 1]Scheme 1

상기 반응식 1에서, 화합물(3)에 NBS(N-브로모석신 이미드)와 벤조일퍼옥사이드를 사용하여 브롬화반응을 한 후 이미노디카르복실산 디-t-부틸 에스테르[(Me3COCO)2NH]를 화합물(4)에 대해 1.1당량 넣은 후 저온에서 60% NaH를 1.2당량 넣고 상온으로 온도를 올리면서 교반 후 감압증류하여 휘발성 물질을 제거한다. 얻어진 화합물(7)은 염산가스를 통과시켜 1차 아민의 염산염을 만든다. 이 때 반응용매를 부피비로 약 1/4까지 증류한 후 디에틸에테르를 가하여 결정을 석출시킴으로써 원하는 화합물(6)을 고체로 얻을 수 있다. 그러나 이 반응에 있어 이미노디카르복실산 디-t-부틸 에스테르[(Me3COCO)2NH]의 가격이 너무 비싸다는 단점이 있다. 이는 향후 상품개발에 있어 대량 생산시 문제가 될 수 있다.In Scheme 1, compound (3) is brominated with NBS (N-bromosuccinimide) and benzoyl peroxide, followed by iminodicarboxylic acid di-t-butyl ester [(Me 3 COCO) 2 NH] is added 1.1 equivalents to Compound (4), 1.2 equivalents of 60% NaH at low temperature is added thereto, the mixture is stirred at room temperature while distilled under reduced pressure, and volatiles are removed. The obtained compound (7) is passed through hydrochloric acid gas to form hydrochloride of the primary amine. At this time, the desired solvent (6) can be obtained as a solid by distilling the reaction solvent to about 1/4 in volume ratio, and then adding crystals to diethyl ether. However, this reaction has the disadvantage that the price of iminodicarboxylic acid di-t-butyl ester [(Me 3 COCO) 2 NH] is too expensive. This may be a problem for mass production in future product development.

상기한 문제점을 해결하고자 본 발명자들은 예의 연구한 결과, 문제의 이미노디카르복실산 디-t-부틸 에스테르를 사용하지 않고서도 상기 화학식 6의 화합물을 고수율로 제조할 수 있다는 사실을 알아내어 본 발명을 완성하기에 이르렀다.In order to solve the above problems, the present inventors have diligently studied to find out that the compound of Formula 6 can be produced in high yield without using the iminodicarboxylic acid di-t-butyl ester. The invention has been completed.

따라서 본 발명의 목적은 하기 화학식 3의 화합물을 브롬화반응시켜 얻어진 화학식 4의 화합물을 아지드화 반응시켜 화학식 5의 화합물을 제조하고, 이어서 이미노포스포란(iminophosphorane) 생성 반응(Staudinger Reaction)시킨 후 가수분해하여 하기 화학식 6의 화합물을 제조하는 방법을 제공하는 것이다:Therefore, an object of the present invention is to prepare a compound of formula 5 by azide-comprising the compound of formula 4 obtained by bromination of the compound of formula 3, and then after iminophosphorane (Staudinger Reaction) It is to provide a method for preparing a compound of formula 6 by hydrolysis:

[화학식 3][Formula 3]

[화학식 4][Formula 4]

[화학식 5][Formula 5]

[화학식 6][Formula 6]

본 발명의 제조방법은 화학식 4의 화합물을 아지드화 반응시키는 단계와 아지드 화합물을 이미노포스포란 생성 반응시켜 가수분해하는 단계로 이루어진다.The preparation method of the present invention comprises azide-forming a compound of Formula 4 and hydrolyzing the azide compound by iminophosphoran production reaction.

상기 아지드화 반응에서, 아지드화제로 사용된 아지드 화합물로서는 N3 -이온을 가진 화합물이면 가능하며, 그의 예는 아지드의 금속염이다. 예를들면, NaN3및 KN3등을 들 수 있다.In the azide reaction, the azide compound used as the azide agent may be a compound having N 3 - ions, an example of which is a metal salt of azide. For example, NaN 3 , KN 3, etc. can be mentioned.

반응 용매는 디메틸포름아미드, 벤젠 및 사염화탄소로 구성된 그룹중에서 선택되며, 반응 진행을 원할히 하기 위하여, 임의로 상전이 촉매를 사용할 수 있다.The reaction solvent is selected from the group consisting of dimethylformamide, benzene and carbon tetrachloride, and in order to facilitate the progress of the reaction, an optional phase transfer catalyst may be used.

상전이 촉매는 벤질트리에틸암모늄 클로라이드, 테트라부틸암모늄 브로마이드, 메틸트리옥틸암모늄 클로라이드 또는 헥사데실트리메틸암모늄 클로라이드 등의 4차 암모늄 화합물이 사용된다. 이들 4차 암모늄 화합물은 큰 유기 그룹을 갖고 있어서 물과 유기 용매 양쪽에 가용성이 있다. NaN3반응의 경우 Na+N3 -는 물층에 녹고, 유기층에는 녹지 않기 때문에, 4차 암모늄 화합물과 반응하여(테트라부틸암모늄 브로마이드의 경우 수층의 Na+N3 -가 Bu4N+N3 -을 형성하여 유기층으로 이동한 후 N3 -가 반응함) 유기층으로 이동하여 반응이 이루어질 수 있다.As the phase transfer catalyst, quaternary ammonium compounds such as benzyltriethylammonium chloride, tetrabutylammonium bromide, methyltrioctylammonium chloride or hexadecyltrimethylammonium chloride are used. These quaternary ammonium compounds have large organic groups and are soluble in both water and organic solvents. For NaN 3 reaction Na + N 3 - is dissolved in the aqueous layer, since there insoluble organic layers, reacted with quaternary ammonium compounds (tetrabutylammonium bromide when Na + N 3 of the water layer-is Bu 4 N + N 3 - the organic layer was formed to move to the N 3 - go to that the reaction), the organic layer may be formed of the reaction.

화학식 5의 아지드 화합물로부터 이미노포스포란 생성반응시킬 때, 트리페닐포스핀(PPh3)존재하에 반응시킴으로써, 생성반응을 촉진시킬 수 있다. 이 때, 트리페닐포스핀 대신에 H2존재하의 Pd/C를 사용할 수도 있으나, 반응중 생기는 N2의 처리문제로 대규모 공정에서는 부적합할 수 있다.When the iminophosphoran production reaction is carried out from the azide compound represented by the formula (5), the reaction can be promoted by reacting in the presence of triphenylphosphine (PPh 3 ). In this case, Pd / C in the presence of H 2 may be used instead of triphenylphosphine, but may be unsuitable in a large-scale process due to a problem of treating N 2 generated during the reaction.

본 발명에서 명세서 전반에 걸쳐 사용된 약호를 설명하면 다음과 같다:In the present invention, the abbreviations used throughout the specification are as follows:

Ac: 아세틸기Ac: Acetyl group

NBS: N-브로모석신 이미드NBS: N-bromosuccinimide

AIBN: 2,2'-아조비스(2-메틸프로피오니트릴)AIBN: 2,2'-azobis (2-methylpropionitrile)

Ph: 페닐Ph: Phenyl

Et: 에틸Et: ethyl

Me: 메틸Me: methyl

EA: 에틸아세테이트EA: ethyl acetate

MDC: 메틸렌 클로라이드MDC: methylene chloride

Boc: 부톡시카보닐Boc: Butoxycarbonyl

THF: 테트라히드로푸란THF: tetrahydrofuran

이하 본 발명을 일예를 들어 제시하면 다음 반응식 2로 나타낼 수 있다.Hereinafter, the present invention can be represented by the following scheme 2 as an example.

[반응식 2]Scheme 2

상기 반응식 2의 반응 조건은 다음과 같이 요약된다.The reaction conditions of Scheme 2 are summarized as follows.

상기 화합물(3)을 시클로헥산, 벤젠 또는 사염화탄소 등에 용해시킨 후 가열하며 0.9당량의 NBS와 0.01당량의 AIBN[2,2-아조비스(2-메틸프로피오니트릴)]을 섞어서 조금씩 넣는다. 이 때 NBS는 0.9당량, AIBN은 0.01당량 사용하며 반응온도는 가용용매에 따라 60∼85℃까지 가능하다. 이렇게 얻은 브로모화합물(4)를 분별증류하여 얻는다. 브로모화합물(4)를 DMF(N,N-디메틸포름아미드) 용매에 녹인 후 물에 녹인 아지드나트륨(NaN3)을 상온에서 적가하여 아지도화합물(5)을 얻을 수 있다. 반응용매를 모두 감압증류 후 얻은 화합물(5)에 테트라히드로퓨란(THF)용매를 가하고 트리페닐포스핀(PPh3) 1.0당량을 30℃가 넘지 않는 온도에서 소분하여 가하고 상온에서 교반한다. 교반 후 물을 넣어 50℃로 가열한다. 이 때 트리페닐포스핀의 양은 1.0∼1.5당량까지 가능하며, 가열 온도는 가용용매에 따라 50∼150℃까지 다양하게 가능하다. 이렇게 얻어진 화합물은 산염기처리후 염산수용액처리하여 반응식 1의 화합물(6)을 고체로 얻을 수 있다.After dissolving the compound (3) in cyclohexane, benzene or carbon tetrachloride, the mixture is heated and mixed with 0.9 equivalent of NBS and 0.01 equivalent of AIBN [2,2-azobis (2-methylpropionitrile)]. In this case, 0.9 equivalents of NBS and 0.01 equivalents of AIBN are used, and the reaction temperature can be up to 60 to 85 ° C. depending on the solvent. The bromo compound (4) thus obtained is obtained by fractional distillation. The azido compound (5) can be obtained by dissolving bromo compound (4) in DMF (N, N-dimethylformamide) solvent and then adding sodium azide (NaN 3 ) dissolved in water dropwise at room temperature. After the reaction solvent was distilled under reduced pressure, tetrahydrofuran (THF) solvent was added to Compound (5), and 1.0 equivalent of triphenylphosphine (PPh 3 ) was added in small portions at a temperature not exceeding 30 ° C, followed by stirring at room temperature. After stirring, water was added and heated to 50 ° C. At this time, the amount of triphenylphosphine can be up to 1.0 to 1.5 equivalents, and the heating temperature can be varied from 50 to 150 ° C. depending on the soluble solvent. The compound thus obtained may be treated with an acid group followed by hydrochloric acid aqueous solution to obtain compound (6) of Scheme 1 as a solid.

한편, 출발물질로서 사용된 화학식 3의 화합물은 상용되는 것을 그대로 사용할 수 있으나, 하기 화학식 1의 화합물을 브롬화 반응시켜 화학식 2의 화합물을 제조하고, 다시 시안화반응 시켜 제조된 것을 사용할 수 있다:On the other hand, the compound of formula 3 used as a starting material can be used as it is commercially available, to prepare a compound of formula 2 by bromination of the compound of formula (1), and can be used to prepare a cyanation again:

[화학식 1][Formula 1]

[화학식 2][Formula 2]

본 발명의 제조방법은 상기 공정을 일체로 하여 진행시킬 수 있다.The manufacturing method of the present invention can be carried out by integrating the above steps.

화학식 3의 화합물을 제조하는 공정에 대한 일예를 들면 다음 반응식 3과 같다:An example of a process for preparing a compound of Formula 3 is shown in Scheme 3:

[반응식 3]Scheme 3

상기 반응식 3을 구체적으로 설명하면, 먼저 첫번째 반응에서 반응용매인 클로로포름과 아세트산을 먼저 넣은 후 NBS(N-브로모숙신 이미드)의 양은 화합물(1)에 대해 0.94당량 사용하며 온도가 상승하는 발열 반응이므로 주의를 요한다. 이 단계에서 NBS를 브롬 대신 사용함으로써 3번 위치에 브롬이 치환되는 위치 선택성이성질체의 발생을 억제할 수 있는 장점이 있다. 이 때 NBS 투입이 완료되면 온도를 상온에서 50℃로 승온시켜준다. 화합물(3)을 만드는 두번째 반응은 CuCN을 1.18당량 사용하며 반응온도 160℃로 6시간 교반한다. 반응 완료 후 암모니아수를 넣고 공기를 통과시키며 14시간 교반한다. 이 때 반응 후 남은 CuCN을 처리하는데 어려움이 있으므로 주의를 요하며, 원하는 화합물(3)은 감압분별증류를 통해 얻을 수 있다.Specifically, Reaction Scheme 3 will be described. First, in the first reaction, chloroform and acetic acid, which are reaction solvents, are first added, and then the amount of NBS (N-bromosuccinimide) is 0.94 equivalents to Compound (1), and the temperature increases. It is a reaction, so it needs attention. In this step, by using NBS instead of bromine, there is an advantage of suppressing the occurrence of position-selective isomers in which bromine is substituted at the 3 position. At this time, when NBS input is completed, the temperature is raised to 50 ° C from room temperature. The second reaction to make compound (3) using 1.18 equivalents of CuCN and stirred for 6 hours at 160 ℃ reaction temperature. After the reaction was completed, ammonia water was added and air was stirred for 14 hours. At this time, attention is required because it is difficult to process the remaining CuCN after the reaction, the desired compound (3) can be obtained through the vacuum distillation.

상기 반응공정중 화합물(2)에서 화합물(3)을 제조할 때, CuCN 대신에 Zn(CN)2+ PdCl2(PPh3)2, 또는 Zn(CN)2+ Pd(PPh3)4를 사용하여 반응시킬 수 있다. 그러나, 이 경우에 CuCN 보다 반응이 잘 일어나는 편은 아니다.In preparing the compound (3) in the compound (2) during the reaction process, Zn (CN) 2 + PdCl 2 (PPh 3 ) 2 , or Zn (CN) 2 + Pd (PPh 3 ) 4 is used instead of CuCN. Can be reacted. However, in this case, the reaction is not better than that of CuCN.

이하 본 발명을 실시예에 의거하여 구체적으로 설명하지만 이들 실시예가 본 발명의 기술적 범위를 한정하는 것은 아니다.Hereinafter, the present invention will be described in detail with reference to Examples, but these Examples do not limit the technical scope of the present invention.

실시예 1 : 2-브로모-5-메틸티오펜(2)의 제조Example 1: Preparation of 2-bromo-5-methylthiophene (2)

클로로포름 300 mL와 아세트산 300 mL의 혼합액에 2-메틸티오펜(1) 49.0 g (0.50 mol)을 가하였다. 실온에서 교반하면서 여기에 NBS 86.2 g (0.47 mol)을 천천히 가하였다 (발열반응: 2340℃). 50℃로 승온하여 3시간 교반한 후 물 600 mL을 가하고 유기층을 분리 한다. 분리된 유기층을 2 N KOH 300 mL 그리고 물 300 mL로 세척한 후 유기층을 분리한다. 분리된 유기층을 MgSO4로 건조, 여과 후 농축하여 2-브로모-5-메틸티오펜(2) 83.0 g (수율: 93.8%)을 수득하였다.49.0 g (0.50 mol) of 2-methylthiophene (1) was added to a mixture of 300 mL of chloroform and 300 mL of acetic acid. While stirring at room temperature, 86.2 g (0.47 mol) of NBS was slowly added thereto (exothermic reaction: 2340 ° C.). After heating to 50 ° C. and stirring for 3 hours, 600 mL of water was added and the organic layer was separated. The separated organic layer was washed with 300 mL of 2 N KOH and 300 mL of water, and then the organic layer was separated. The separated organic layer was dried over MgSO 4 , filtered and concentrated to give 83.0 g (yield: 93.8%) of 2-bromo-5-methylthiophene (2).

1H NMR (CDCl3) δ 6.81 (d, 1H), 6.51 (m, 1H), 2.43 (s, 3H) 1 H NMR (CDCl 3 ) δ 6.81 (d, 1H), 6.51 (m, 1H), 2.43 (s, 3H)

FAB MS: 178 [M+1]+ FAB MS: 178 [M + 1] +

실시예 2: 5-메틸-2-티오펜카보니트릴(3)의 제조Example 2: Preparation of 5-methyl-2-thiophencarbonitrile (3)

2-브로모-5-메틸티오펜(2) 58.0 g (0.33 mol)을 DMF 170 mL에 용해시킨 후 CuCN 35.2 g (0.39 mol)을 가하고 160℃에서 6시간 교반하였다. 반응 완료 후 뜨거운 반응액에 암모니아수 300 mL을 가하고 공기를 통과시키며 14시간 교반하였다. 혼합액을 여과하여 고체을 제거한 후 Et2O 500 mL로 추출하고 다시 200 mL로 추출하였다. 유기층을 모아 0.5 N HCl 300 mL, 그 후 물 300 mL로 세척하였다. MgSO4로 건조, 여과 후 농축하고 감압 증류하여 5-메틸-2-티오펜카보니트릴(3) 23.5 g (수율: 57.9%)을 수득하였다.58.0 g (0.33 mol) of 2-bromo-5-methylthiophene (2) was dissolved in 170 mL of DMF, and then 35.2 g (0.39 mol) of CuCN was added thereto, and the mixture was stirred at 160 ° C. for 6 hours. After the reaction was completed, 300 mL of ammonia water was added to the hot reaction solution, and the mixture was stirred for 14 hours while passing through air. The mixture was filtered to remove solids, extracted with 500 mL of Et 2 O, and then extracted with 200 mL. The combined organic layers were washed with 300 mL of 0.5 N HCl and then 300 mL of water. Drying with MgSO 4 , filtration, concentration and distillation under reduced pressure yielded 23.5 g (yield: 57.9%) of 5-methyl-2-thiophencarbonitrile (3).

1H NMR (CDCl3) δ 7.43 (d, 1H), 6.77 (d, 1H), 2.55 (s, 2H) 1 H NMR (CDCl 3 ) δ 7.43 (d, 1H), 6.77 (d, 1H), 2.55 (s, 2H)

FAB MS: 124 [M+1]+ FAB MS: 124 [M + 1] +

실시예 3. 5-브로모메틸-2-티오펜카보니트릴(4)의 제조Example 3. Preparation of 5-bromomethyl-2-thiophencarbonitrile (4)

5-메틸-2-티오펜카보니트릴(3) 35.0 g (0.284 mol)을 벤젠 210mL에 용해시킨다. 용액을 가열 환류시키며 NBS 45.5 g (0.256 mol)과 AIBN 4.66 g (0.028 mol)의 혼합물을 조금씩 가하였다. 1 시간 후 실온으로 냉각하고 5% 탄산수소나트륨 용액 210 mL 그리고 10% 소금물 100 mL로 세척하였다. MgSO4로 건조, 여과 후 농축하고 감압분별증류하여 정제된 5-브로모메틸-2-티오펜카보니트릴(4) 33.1 g (수율: 63.9%)을 수득하였다.35.0 g (0.284 mol) of 5-methyl-2-thiophencarbonitrile (3) is dissolved in 210 mL of benzene. The solution was heated to reflux and a mixture of 45.5 g (0.256 mol) NBS and 4.66 g (0.028 mol) AIBN was added in portions. After 1 hour it was cooled to room temperature and washed with 210 mL of 5% sodium bicarbonate solution and 100 mL of 10% brine. MgSO4, 5-bromomethyl-2-thiophencarbonitrile (4) 33.1 g (yield: 63.9%) were obtained.

1H NMR (CDCl3) δ 7.47 (d, 1H), 7.10 (d, 1H), 4.64 (s, 2H) 1 H NMR (CDCl 3 ) δ 7.47 (d, 1H), 7.10 (d, 1H), 4.64 (s, 2H)

FAB MS: 203 [M+1]+ FAB MS: 203 [M + 1] +

실시예 4. 5-아미노메틸-2-티오펜카보니트릴.HCl (6)의 제조.Example 4. 5-Aminomethyl-2-thiophencarbonitrile. Preparation of HCl (6).

5-브로모메틸-2-티오펜카보니트릴(4) 214.1 g (1.74 mol)을 DMF 1.2 L에 용해시킨 후, NaN3169.7 g (2.61 mol)를 H2O 0.4 L에 녹인 용액을 상온에서 0.5 시간에 걸쳐 적가하였다. 상온에서 4 시간 교반 후 EtOAc 1.2 L와 H2O 1.2 L를 반응액에 가하였다. 분리된 수층을 EtOAc 1 L로 두번 추출하고 유기층을 모아서 물 1L로 세척하였다. 유기층을 분리하여 MgSO4로 건조, 여과하고 감압하여 농축하였다. 전체 부피가 1 L가 되었을 때 THF 1 L를 추가하고 다시 감압 증류하다가, 전체 부피가 1 L가 되었을 때 증류를 중지하였다. 잔류액에 THF 1 L를 추가하고, 30 ℃가 넘지 않는 범위에서 PPh3456.4 g (1.74 mol)을 1 시간 동안 가하였다(넣을 때마다 발열이 많이 되고 거품도 많이 생기므로 주의한다). 실온에서 1 시간 교반한 후 H2O313 mL (17.4 mol)을 넣고 50 ℃로 가열하였다. 3 시간 후 감압증류하여 휘발성 물질을 제거하고 농축액에 MDC 2 L를 가하였다. 2 N HCl 1 L로 두번 추출한 후 수층을 모아서 MDC 1 L로 세척하였다. 수층을 10 ℃로 냉각하고 20 ℃가 넘지 않도록 하면서 NaOH를 조금씩 넣어 pH를 약 10에 맞추었다. 수층을 MDC 1 L로 세번 추출하였다. 분리된 유기층을 MgSO4로 건조, 여과하고 휘발성 물질을 제거한 후, 농축액에 Et2O 2 L를 가한다. 반응액을 냉각하며 약 3.8 N HCl EtOAc 용액 0.44 L를 25 ℃가 넘지 않도록 조금씩 가하였다. 실온에서 2시간 동안 교반후 여과하고 필터 케이크(filter cake)를 Et2O 0.5 L로 닦은 후 질소로 건조하였다. 건조질량: 197.3 g (수율: 64.9%)5-bromomethyl-2-thiophencarbonitrile (4) 214.1 g (1.74 mol) was dissolved in 1.2 L of DMF, followed by NaN3169.7 g (2.61 mol) to H2A solution dissolved in 0.4 L of O was added dropwise at room temperature over 0.5 hour. After stirring for 4 hours at room temperature, EtOAc 1.2 L and H21.2 L of O was added to the reaction solution. The separated aqueous layer was extracted twice with 1 L of EtOAc and the combined organic layers were washed with 1 L of water. MgSO by separating organic layer4Dried over, filtered and concentrated under reduced pressure. 1 L of THF was added when the total volume became 1 L and distilled under reduced pressure again, and distillation was stopped when the total volume became 1 L. 1 L of THF is added to the residue, and PPh within the range not exceeding 30 ° C.3456.4 g (1.74 mol) was added for 1 hour (note that it generates a lot of fever and bubbles every time). After stirring for 1 hour at room temperature2O313 mL (17.4 mol) was added and heated to 50 ° C. After 3 hours, the mixture was distilled under reduced pressure to remove volatiles, and MDC 2 L was added to the concentrate. After extracting twice with 1 L of 2N HCl, the aqueous layers were collected and washed with 1 L of MDC. The aqueous layer was cooled to 10 ° C. and the pH was adjusted to about 10 by adding NaOH little by little while not exceeding 20 ° C. The aqueous layer was extracted three times with 1 L of MDC. MgSO separated organic layer4Dry with filtration, remove volatiles, and concentrate Et into concentrate2O 2 L is added. The reaction solution was cooled and 0.44 L of about 3.8 N HCl EtOAc solution was added little by little to no more than 25 ° C. After stirring for 2 hours at room temperature, the mixture was filtered and the filter cake was washed with Et.2O was washed with 0.5 L and dried with nitrogen. Dry Mass: 197.3 g (Yield: 64.9%)

1H NMR (CD3OD) δ 7.77 (d, 1H), 7.34 (d, 1H), 4.41 (s, 2H) 1 H NMR (CD 3 OD) δ 7.77 (d, 1H), 7.34 (d, 1H), 4.41 (s, 2H)

FAB MS: 139 [M+1]+ FAB MS: 139 [M + 1] +

본 발명의 제조방법에 따라 상기 화학식 1의 화합물로부터 항응혈제 제조용 중간체를 대량생산 뿐만아니라 고수율로 합성할 수 있다.According to the preparation method of the present invention, the intermediate for preparing an anticoagulant may be synthesized from the compound of Chemical Formula 1 in high yield as well as in mass production.

Claims (7)

하기 화학식 3의 화합물을 브롬화반응시켜 얻어진 화학식 4의 화합물을 아지드화 반응시켜 화학식 5의 화합물을 제조하고, 이어서 이미노포스포란(iminophosphorane) 생성 반응(Staudinger Reaction)시킨 후 가수분해하는 것을 특징으로 하여 하기 화학식 6의 화합물을 제조하는 방법:To azide the compound of formula (4) obtained by bromination of the compound of formula (3) to prepare a compound of formula (5), then iminophosphorane (Stinophosphorane) production reaction (Staudinger Reaction) characterized in that the hydrolysis To prepare a compound of formula [화학식 3][Formula 3] [화학식 4][Formula 4] [화학식 5][Formula 5] [화학식 6][Formula 6] 제 1 항에 있어서, 아지드화 반응에서 아지드화제가 NaN3및 KN3로 구성된 그룹중에서 선택되는 방법.The method of claim 1 wherein the azide agent in the azide reaction is selected from the group consisting of NaN 3 and KN 3 . 제 1 항에 있어서, 아지드화 반응에서 반응용매가 디메틸포름아미드, 벤젠 및 사염화탄소로 구성된 그룹중에서 선택되는 방법.The process according to claim 1, wherein the reaction solvent in the azide reaction is selected from the group consisting of dimethylformamide, benzene and carbon tetrachloride. 제 1 항에 있어서, 아지드화 반응을 상전이 촉매 존재하에 반응시키는 방법.The process of claim 1 wherein the azide reaction is reacted in the presence of a phase transfer catalyst. 제 4 항에 있어서, 상전이 촉매가 벤질트리에틸암모늄 클로라이드, 테트라부틸암모늄 브로마이드, 메틸트리옥틸암모늄 클로라이드 및 헥사데실트리메틸암모늄 클로라이드로 구성된 그룹중에서 선택되는 방법.The process of claim 4 wherein the phase transfer catalyst is selected from the group consisting of benzyltriethylammonium chloride, tetrabutylammonium bromide, methyltrioctylammonium chloride and hexadecyltrimethylammonium chloride. 제 1 항에 있어서, 이미노포스포란 생성반응을 트리페닐포스핀 존재하에 수행하는 방법.The method of claim 1 wherein the iminophosphoran production reaction is carried out in the presence of triphenylphosphine. 제 1 항에 있어서, 화학식 3의 화합물로 하기 화학식 1의 화합물을 브롬화 반응시켜 화학식 2의 화합물을 제조하고, 다시 시안화반응시켜 제조된 것을 사용하는 방법:The method according to claim 1, wherein the compound of formula 1 is brominated with a compound of formula 3 to prepare a compound of formula 2, and then cyanated to be used. [화학식 1][Formula 1] [화학식 2][Formula 2]
KR10-2001-0017841A 2001-04-04 2001-04-04 Process for preparing 5-aminomethyl-2-thiophenecarbonitrile·HCl KR100403950B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR10-2001-0017841A KR100403950B1 (en) 2001-04-04 2001-04-04 Process for preparing 5-aminomethyl-2-thiophenecarbonitrile·HCl

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2001-0017841A KR100403950B1 (en) 2001-04-04 2001-04-04 Process for preparing 5-aminomethyl-2-thiophenecarbonitrile·HCl

Publications (2)

Publication Number Publication Date
KR20020078025A KR20020078025A (en) 2002-10-18
KR100403950B1 true KR100403950B1 (en) 2003-10-30

Family

ID=27699841

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2001-0017841A KR100403950B1 (en) 2001-04-04 2001-04-04 Process for preparing 5-aminomethyl-2-thiophenecarbonitrile·HCl

Country Status (1)

Country Link
KR (1) KR100403950B1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3741984A (en) * 1971-08-19 1973-06-26 Du Pont N-sulfamoyl-2-thiopenecarboxamides
US5369124A (en) * 1992-10-02 1994-11-29 Bayer Aktiengesellschaft Substituted thiophenecarboxamides
US5869427A (en) * 1996-06-11 1999-02-09 Mitsui Chemicals, Inc. Substituted thiophene derivative and plant disease control agent comprising the same as active ingredient

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3741984A (en) * 1971-08-19 1973-06-26 Du Pont N-sulfamoyl-2-thiopenecarboxamides
US5369124A (en) * 1992-10-02 1994-11-29 Bayer Aktiengesellschaft Substituted thiophenecarboxamides
US5869427A (en) * 1996-06-11 1999-02-09 Mitsui Chemicals, Inc. Substituted thiophene derivative and plant disease control agent comprising the same as active ingredient

Also Published As

Publication number Publication date
KR20020078025A (en) 2002-10-18

Similar Documents

Publication Publication Date Title
CN110526859B (en) Revinanexin intermediate, preparation method thereof and preparation method of Revinanexin
CN103570696B (en) A kind of preparation method of Axitinib intermediate and preparing the application in Axitinib
CN114805314A (en) Synthesis method of Ensaitevir
CN108373468B (en) Preparation method of N-2-pyridine-5-pyrimidine methylamine
KR102314436B1 (en) Process for Preparing Nafamostat Mesilate and Intermediate Thereof
CN105646285B (en) One kind dimension Lactel sieve intermediate and its preparation method and application
JP2007230963A (en) Method for producing 2,4-disubstituted pyridine
KR100403950B1 (en) Process for preparing 5-aminomethyl-2-thiophenecarbonitrile·HCl
CN101939289A (en) Novel process for the preparation of vorinostat
CN107652271B (en) Preparation method of topiroxostat crystal form I
JPH0421674A (en) Production of 2-chloro-5-(aminomethyl)thiazole
KR100447421B1 (en) Novel process for preparing 5-aminomethyl-2-thiophenecarbonitrile·HCl by one-pot reaction
JPH03271273A (en) Production of 2-chloro-5-(aminomethyl)pyridine
KR101348304B1 (en) Method of preparing of (2Z)-3-[(6-methylpyridin-3-yl)methyl-1,3-thiazolidin-2-ylidene]cyanamice
CN110590641B (en) Green preparation method of 3-hydroxyisoindole-1-ketone series compounds
JP5279449B2 (en) Process for producing 5- {4- [2- (5-ethyl-2-pyridyl) ethoxy] benzyl} -2,4-thiazolidinedione hydrochloride
JPH06184132A (en) Benzofuran derivative, its production and uricosuric agent
JPH0395192A (en) Azo compound
JP2716243B2 (en) N-benzyl-3-hydroxysuccinamic acid and method for producing the same
JP3185482B2 (en) Nitrilation method
JP2007246400A (en) Fluorene skeleton-containing phthalimides and diamines derived therefrom
CN113979887A (en) Synthetic method of aromatic amine carboxylic acid derivative
JPS6210500B2 (en)
JPH01168664A (en) Cyclohexenone derivative and production thereof
KR20230032513A (en) Method for preparing Camostat mesylate

Legal Events

Date Code Title Description
A201 Request for examination
N231 Notification of change of applicant
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20060915

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee